World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Looking East, Big Pharma Cuts Prices
Keywords:
Tags:
The western pharmaceutical companies see the potential for a big increase in sales in developing countries with better pricing to reach a larger number of people. Earlier this year Glaxo said it planned to reduce prices to two thirds of the levels in western countries, and charge 25% of prices in western nations to people in the 50 poorest countries. As a result Glaxo now forecasts a 10% increase in sales in 2010 in the Asia-Pacific area, after a 9% increase in 2009. The overall impact on public health will however be limited as even with this price reduction these medicines will benefit a fraction of the people. Today the combined pharmaceutical sales in Asia, Africa and Australia are $90.8 billon. According to IMS seventeen economies including China, India, Russia and Brazil will see pharma spending grow by $90 billion in a five year period 2009-2014. Of this China's demand will grow by $40 billion in this IMS Report on "phamemerging" economies. The upshot: phamemerging will account for 20% of global sales by 2013, up from 16% in 2008.
Pharmaceutical product sales in emerging countries
04/15/2010
Sales of pharmaceutical products in Brazil, India, China, Russia and other emerging market countries as major pharmaceutical companies reduce prices to have broader access to these markets.
Grouped Articles
Looking East, Big Pharma Cuts Prices
BusinessWeek 04/15/2010
Abbott Looks to India for Shot in Arm
Wall Street Journal 08/26/2010
India Administers Price-Cap Dose to Drug Companies
Wall Street Journal 09/22/2014
China Worries Could Hurt Pharma’s Health
Wall Street Journal 08/24/2015
Chinese Market Offers New Life to Many Drugs
Wall Street Journal 03/30/2016
Glaxo China
04/15/2010
Grouped Articles
GlaxoSmithKline Probes Bribe Allegations in China
Wall Street Journal 06/12/2013
GlaxoSmithKline Accused of Corruption by China
New York Times 07/11/2013
Wall Street Journal 07/16/2013
Glaxo Cites Possible Violations in China
Wall Street Journal 07/23/2013
Looking East, Big Pharma Cuts Prices
BusinessWeek 04/15/2010
Glaxo Names New China Chief Amid Bribery Probe
Wall Street Journal 07/26/2013
Novartis in emerging markets
04/15/2010
Grouped Articles
Looking East, Big Pharma Cuts Prices
BusinessWeek 04/15/2010
Abbott in emerging markets.
02/26/2009
Grouped Articles
Emerging Markets Are on Their Own
Wall Street Journal 06/23/2013
Looking East, Big Pharma Cuts Prices
BusinessWeek 04/15/2010
Abbott Plant Is New Move To Tap Asia
Wall Street Journal 02/26/2009
Abbott Labs to Buy Indian Drug Maker
Wall Street Journal 05/22/2010
Abbott Labs to Buy Indian Drug Maker
Wall Street Journal 05/22/2010
Abbott Labs Spices Up Its Drug Portfolio
Wall Street Journal 05/22/2010
Pfizer in emerging markets
04/15/2010
Grouped Articles
Looking East, Big Pharma Cuts Prices
BusinessWeek 04/15/2010
Abbott Looks to India for Shot in Arm
Wall Street Journal 08/26/2010
Pfizer's New CEO Challenged Overseas
Wall Street Journal 12/10/2010
Life Beyond Lipitor for Pfizer Chief
Wall Street Journal 05/02/2011
Indiaâs Supreme Court to Hear Dispute on Drug Patents
New York Times 03/06/2012
Pfizer Profit Declines 19% After Loss of Lipitor Patent
New York Times 05/01/2012
China's pharmaceutical market 2010-2016
12/30/2005
Grouped Articles
Looking East, Big Pharma Cuts Prices
BusinessWeek 04/15/2010
China Worries Could Hurt Pharma’s Health
Wall Street Journal 08/24/2015
Chinese Market Offers New Life to Many Drugs
Wall Street Journal 03/30/2016
The Four Ps of Global Business Expansion
Wall Street Journal 11/12/2010
China's Workers See Thin Protection In Insurance Plans
Wall Street Journal 12/30/2005
BusinessWeek 11/10/2011
The pharmaceutical market in Russia
04/15/2010
Grouped Articles
Looking East, Big Pharma Cuts Prices
BusinessWeek 04/15/2010
Patent protection for western pharmaceutical companies in emerging markets.
04/24/2007
Efforts by western companies to secure patent protection and the situation in different developing countries.
Grouped Articles
Looking East, Big Pharma Cuts Prices
BusinessWeek 04/15/2010
Abbott Looks to India for Shot in Arm
Wall Street Journal 08/26/2010
Economist 08/08/2015
Thai Showdown Spotlights Threat to Drug Patents
Wall Street Journal 04/24/2007
India Rejects Novartis Patent Claim
Wall Street Journal 07/07/2009
India Prepares EU Trade Complaint
Wall Street Journal 08/06/2009
Glaxo in the pharmaceutical market in China
04/15/2010
Grouped Articles
GlaxoSmithKline Probes Bribe Allegations in China
Wall Street Journal 06/12/2013
Wall Street Journal 07/16/2013
Glaxo Cites Possible Violations in China
Wall Street Journal 07/23/2013
Looking East, Big Pharma Cuts Prices
BusinessWeek 04/15/2010
Glaxo Names New China Chief Amid Bribery Probe
Wall Street Journal 07/26/2013
Wall Street Journal 10/24/2013
Sanofi in emerging markets
04/15/2010
Grouped Articles
Looking East, Big Pharma Cuts Prices
BusinessWeek 04/15/2010
Abbott Looks to India for Shot in Arm
Wall Street Journal 08/26/2010
Abbott Labs India
04/15/2010
Grouped Articles
Looking East, Big Pharma Cuts Prices
BusinessWeek 04/15/2010
Abbott Buys Drug Maker in India for $3.7 Billion
New York Times 05/21/2010
Abbott Labs Spices Up Its Drug Portfolio
Wall Street Journal 05/22/2010
Abbott Labs to Buy Indian Drug Maker
Wall Street Journal 05/22/2010
Indian pharmaceutical companies and the growing demand in India.
02/09/2006
The rapidly growing Indian pharmaceutical companies. The Indian market $8 billion today will grow to $30 billion in the next 10 years as more people get access to better healthcare. Sales in the Middle East, Africa and Latin America, and outsourcing manufacture for western companies are additional sources of growth for these companies.
Grouped Articles
Looking East, Big Pharma Cuts Prices
BusinessWeek 04/15/2010
India Administers Price-Cap Dose to Drug Companies
Wall Street Journal 09/22/2014
Indian Drug Maker Vies for Betapharm
Wall Street Journal 02/09/2006
Economist 11/08/2007
India's Drug Firms May Boost a Healthy Portfolio
Wall Street Journal 12/17/2007
Indian Companies Hit Their Stride
BusinessWeek 09/17/2007
The pharmaceutical market in Brazil
04/15/2010
Grouped Articles
Looking East, Big Pharma Cuts Prices
BusinessWeek 04/15/2010
Novartis in China and emerging markets.
10/02/2006
Grouped Articles
China Worries Could Hurt Pharma’s Health
Wall Street Journal 08/24/2015
Novartis Cuts Price of Coartem To Help Fight Malaria in Africa - WSJ.com
Wall Street Journal 10/02/2006
Novartis to Establish Drug R&D Center in China - WSJ.com
Wall Street Journal 11/06/2006
Novartis Angers Critics in India
Wall Street Journal 03/05/2007
India Rejects Novartis Patent Claim
Wall Street Journal 07/07/2009
Novartis Mounts Ambitious Push Into China
Wall Street Journal 11/04/2009
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us